The Retatrutide and Cagrilintide stack covers four metabolic pathways, more than any other common pairing
Dosing above 500 mcg does not proportionally increase efficacy
The FDA established two deadlines
Batch-specific certificate of analysis, third-party HPLC purity data, mass-spectrometry identity confirmation, and clear research-use-only labelling
GHK-Cu acts at the extracellular matrix (ECM) level, modulating the balance between matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) to regulate collagen turnover, and stimulating fibroblasts to produce collagen type I, collagen type III, and elastin
In the early 1970s, biochemist Loren Pickart discovered something unusual in human blood plasma